309 related articles for article (PubMed ID: 33116497)
1. Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer.
Pangeni R; Subedi L; Jha SK; Kweon S; Kang SH; Chang KY; Choi JU; Byun Y; Park JW
Int J Nanomedicine; 2020; 15():7719-7743. PubMed ID: 33116497
[TBL] [Abstract][Full Text] [Related]
2. Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative.
Pangeni R; Jha SK; Maharjan R; Choi JU; Chang KY; Choi YK; Byun Y; Park JW
Int J Nanomedicine; 2019; 14():6339-6356. PubMed ID: 31496690
[TBL] [Abstract][Full Text] [Related]
3. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.
Pangeni R; Choi JU; Panthi VK; Byun Y; Park JW
Int J Nanomedicine; 2018; 13():3329-3351. PubMed ID: 29922055
[TBL] [Abstract][Full Text] [Related]
4. Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.
Pangeni R; Choi SW; Jeon OC; Byun Y; Park JW
Int J Nanomedicine; 2016; 11():6379-6399. PubMed ID: 27942212
[TBL] [Abstract][Full Text] [Related]
5. Absorption Mechanism of a Physical Complex of Monomeric Insulin and Deoxycholyl-l-lysyl-methylester in the Small Intestine.
Mahmud F; Jeon OC; Al-Hilal TA; Kweon S; Yang VC; Lee DS; Byun Y
Mol Pharm; 2015 Jun; 12(6):1911-20. PubMed ID: 25892399
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling.
Jha SK; Chung JY; Pangeni R; Choi HS; Subedi L; Kweon S; Choi JU; Byun Y; Kim YH; Park JW
J Control Release; 2020 Dec; 328():368-394. PubMed ID: 32890552
[TBL] [Abstract][Full Text] [Related]
7. Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex.
Jha SK; Han HS; Subedi L; Pangeni R; Chung JY; Kweon S; Choi JU; Byun Y; Kim YH; Park JW
Drug Deliv; 2020 Dec; 27(1):1501-1513. PubMed ID: 33107339
[TBL] [Abstract][Full Text] [Related]
8. Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunity.
Maharjan R; Subedi L; Pangeni R; Jha SK; Kang SH; Chang KY; Byun Y; Choi JU; Park JW
Drug Deliv; 2021 Dec; 28(1):2313-2328. PubMed ID: 34730056
[TBL] [Abstract][Full Text] [Related]
9. Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy.
Maharjan R; Pangeni R; Jha SK; Choi JU; Chang KY; Choi YK; Park JW; Byun Y
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31337061
[TBL] [Abstract][Full Text] [Related]
10. Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer.
Mahmud F; Jeon OC; Alam F; Maharjan R; Choi JU; Park J; Lee S; Park JW; Lee DS; Byun Y
J Control Release; 2018 Aug; 284():160-170. PubMed ID: 29908222
[TBL] [Abstract][Full Text] [Related]
11. Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion.
Choi JU; Maharjan R; Pangeni R; Jha SK; Lee NK; Kweon S; Lee HK; Chang KY; Choi YK; Park JW; Byun Y
J Control Release; 2020 Jun; 322():13-30. PubMed ID: 32169534
[TBL] [Abstract][Full Text] [Related]
12. Ionic complex of risedronate with positively charged deoxycholic acid derivative: evaluation of physicochemical properties and enhancement of intestinal absorption in rats.
Park JW; Byun Y
Arch Pharm Res; 2014 Dec; 37(12):1560-9. PubMed ID: 24254935
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral absorption of ibandronate via complex formation with bile acid derivative.
Park JW; Hwang SR; Jeon OC; Moon HT; Byun Y
J Pharm Sci; 2013 Feb; 102(2):341-6. PubMed ID: 23233267
[TBL] [Abstract][Full Text] [Related]
15. Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management.
Mahmud F; Chung SW; Alam F; Choi JU; Kim SW; Kim IS; Kim SY; Lee DS; Byun Y
J Control Release; 2017 Mar; 249():42-52. PubMed ID: 28093298
[TBL] [Abstract][Full Text] [Related]
16. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.
Vasconcelos T; Prezotti F; Araújo F; Lopes C; Loureiro A; Marques S; Sarmento B
Int J Pharm; 2021 Feb; 595():120245. PubMed ID: 33484925
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers.
Hou J; Wang J; Sun E; Yang L; Yan HM; Jia XB; Zhang ZH
Drug Deliv; 2016 Nov; 23(9):3248-3256. PubMed ID: 26984338
[TBL] [Abstract][Full Text] [Related]
18. Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolayers and reduce its intestinal absorption in rat.
Chen G; Fawcett JP; Mikov M; Tucker IG
J Pharm Pharmacol; 2009 Jul; 61(7):953-9. PubMed ID: 19589239
[TBL] [Abstract][Full Text] [Related]
19. The efficiency and mechanism of a new absorption enhancer, malic acid, for enhancing the oral bioavailability of docetaxel.
Guo XH; Ding F; Lian X; Cui W; Li Z; Xing Y
Pharm Dev Technol; 2021 Jun; 26(5):592-598. PubMed ID: 33734909
[TBL] [Abstract][Full Text] [Related]
20. A novel drug-phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo.
Xia HJ; Zhang ZH; Jin X; Hu Q; Chen XY; Jia XB
Int J Nanomedicine; 2013; 8():545-54. PubMed ID: 23431115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
